Proposed issue of securities - AMS
Released
Released
Announcement PDF
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 1 / 5
Announcement Summary
Entity name
ATOMOS LIMITED
Announcement Type
New announcement
Date of this announcement
13/4/2026
The Proposed issue is:
Total number of +securities proposed to be issued for a placement or other type of issue
ASX +security code +Security description
Maximum Number of
+securities to be issued
AMS ORDINARY FULLY PAID 35,602,592
Proposed +issue date
31/5/2029
Refer to next page for full details of the announcement
A placement or other type of issue
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 2 / 5
Part 1 - Entity and announcement details
1.1 Name of +Entity
ATOMOS LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees
to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in
Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also
apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set
out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under
the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX
an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 Registered Number Type
ABN
Registration Number
25139730500
1.3 ASX issuer code
AMS
1.4 The announcement is
1.5 Date of this announcement
13/4/2026
1.6 The Proposed issue is:
A placement or other type of issue
New announcement
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 3 / 5
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other
type of issue can proceed on an unconditional basis?
Part 7B - Issue details
Is the proposed security a 'New
class' (+securities in a class that is
not yet quoted or recorded by ASX)
or an 'Existing class' (additional
securities in a class that is already
quoted or recorded by ASX)?
Will the proposed issue of this
+security include an offer of
attaching +securities?
Details of +securities proposed to be issued
ASX +security code and description
AMS : ORDINARY FULLY PAID
Number of +securities proposed to be issued
5,602,592
Offer price details
Are the +securities proposed to be issued being issued for a cash
consideration?
Please describe the consideration being provided for the +securities
As part of the acquisition of Flanders Scientific, as notified to the ASX on 13 April 2026 utilising the 30-day
VWAP of 1.75c to be issued by the end of May 2026.
Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities
98,045.360000
Will these +securities rank equally in all respects from their issue date with
the existing issued +securities in that class?
Is the proposed security a 'New
class' (+securities in a class that is
not yet quoted or recorded by ASX)
or an 'Existing class' (additional
Will the proposed issue of this
+security include an offer of
attaching +securities?
Yes
No
No
Existing class
No
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 4 / 5
or an 'Existing class' (additional
securities in a class that is already
quoted or recorded by ASX)?
Details of +securities proposed to be issued
ASX +security code and description
AMS : ORDINARY FULLY PAID
Number of +securities proposed to be issued
30,000,000
Offer price details
Are the +securities proposed to be issued being issued for a cash
consideration?
Please describe the consideration being provided for the +securities
As part of the acquisition of Flanders Scientific, as notified to the ASX on 13 April 2026. Up to 30,000,000 fully paid
ordinary shares in Atomos to be issued in equal instalments over the next 3 years, subject to ongoing business operation
and performance, utilising the 30-day VWAP of 1.75c
Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities
525,000.000000
Will these +securities rank equally in all respects from their issue date with
the existing issued +securities in that class?
Part 7C - Timetable
7C.1 Proposed +issue date
31/5/2029
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1?
7D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15%
placement capacity under listing rule 7.1?
7D.1b ( i ) How many +securities are proposed to be issued without security holder approval using the entity's 15%
placement capacity under listing rule 7.1?
5,602,592 shares plus up to 30,000,000 fully paid ordinary shares, to be issued in equal instalments over the next 3 years,
subject to ongoing business operation and performance.
Yes
No
Yes
No
No
Existing class
Appendix 3B - Proposed issue of securities
Appendix 3B - Proposed issue of securities 5 / 5
7D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's
additional 10% placement capacity under listing rule 7.1A (if applicable)?
7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue?
7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?
7D.4 Will any of the +securities to be issued be subject to +voluntary escrow?
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the proposed issue?
7E.2 Is the proposed issue to be underwritten?
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
As part of the consideration for the acquisition of Flanders Scientific, as notified to the ASX on 13 April 2026
7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?
7F.2 Any other information the entity wishes to provide about the proposed issue
7F.3 Any on-sale of the +securities proposed to be issued within 12 months of their date of issue will comply with
the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of:
The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)
No
No
No
No
No
No
No
Share your feedback
Discover